5AM delivered the clinical version of Oncomine™, which allows physicians to compare their patients’ genetic signatures against large data sets to determine the most effective drug protocols. A seamless transfer of the bioinformatics data into easy-to-use, actionable information is now possible with the treating physician portal.

5AM incorporated the Compendia oncology workflow within Thermo Fisher’s Ion Reporter™ software to accelerate their lead in building the most robust bioinformatics offering in the industry. Researchers sequencing tumor samples on the Ion Personal Genome Machine (PGM™), for example, can leverage the insight gained from the thousands of samples already in Compendia’s database in an effort to identify targetable mutations.